Pfizer Recalls Daptomycin Injection Due to Microbial Contamination
Pfizer is recalling Daptomycin for Injection due to reports of adverse events indicative of infusion reactions related to microbiological contamination.
- Product
- Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-0106-01.
- Category
- Drug
- Distribution
- Distributed nationwide